Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Nov 7, 2025The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Zen Rating | Financials | Market Cap | ROE | ROA | ROCE | ROIC | D/E | Current Ratio | Gross Margin | Profit Margin | Operating Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DXCM | DEXCOM INC | A | B | $23.12B | 29.80% | 10.30% | 23.49% | 19.00% | 1.75 | 1.57 | 59.00% | 16.00% | 21.66% |
| SGHC | SUPER GROUP (SGHC) LTD | A | B | $6.17B | 33.00% | 19.40% | 44.60% | 268.00% | 0.60 | 1.75 | 30.60% | 10.00% | 16.84% |
| GTES | GATES INDUSTRIAL CORP PLC | A | C | $5.64B | 7.40% | 3.40% | 7.12% | 9.50% | 1.02 | 3.52 | 40.40% | 6.90% | 13.43% |
| TGTX | TG THERAPEUTICS INC | A | C | $5.40B | 26.10% | 9.60% | 18.37% | 16.60% | 1.54 | 3.86 | 87.00% | 13.30% | 21.47% |
| SEE | SEALED AIR CORP | A | B | $5.38B | 51.00% | 6.40% | 13.40% | 11.70% | 4.95 | 1.29 | 30.10% | 8.50% | 13.94% |
| MMSI | MERIT MEDICAL SYSTEMS INC | A | B | $5.16B | 8.10% | 4.70% | 7.54% | 10.00% | 0.72 | 4.28 | 48.50% | 8.00% | 12.26% |
| RSI | RUSH STREET INTERACTIVE INC | A | A | $3.81B | 28.90% | 6.30% | -17.56% | 415.80% | 2.40 | 1.91 | 35.10% | 2.80% | -6.82% |
| MIRM | MIRUM PHARMACEUTICALS INC | A | B | $3.52B | -24.80% | -8.50% | -7.40% | -10.50% | 1.85 | 3.13 | 79.00% | -13.60% | -10.02% |
| EXTR | EXTREME NETWORKS INC | A | B | $2.36B | 13.50% | 0.80% | 6.39% | 19.30% | 15.82 | 0.91 | 61.60% | 0.70% | 3.12% |
| SPNT | SIRIUSPOINT LTD | A | C | $2.27B | 8.80% | 1.50% | N/A | 2.70% | 4.64 | N/A | 46.70% | 6.40% | 11.52% |
| IHS | IHS HOLDING LTD | A | B | $2.22B | -28.60% | 2.50% | 23.79% | 15.20% | -16.94 | 1.54 | 50.70% | 6.40% | 52.89% |
| ARDT | ARDENT HEALTH INC | A | B | $2.10B | 22.30% | 5.20% | 9.43% | 8.10% | 2.70 | 2.13 | 18.30% | 4.10% | 6.31% |
| NTCT | NETSCOUT SYSTEMS INC | A | C | $1.95B | -24.60% | -17.20% | -20.16% | -354.50% | 0.40 | 1.75 | 78.30% | -44.60% | -43.59% |
| FIVN | FIVE9 INC | A | C | $1.76B | 1.40% | 0.40% | 1.49% | 1.20% | 1.38 | 4.44 | 54.90% | 0.80% | 2.02% |
| BLBD | BLUE BIRD CORP | A | A | $1.63B | 61.70% | 21.30% | 46.17% | 78.20% | 1.59 | 1.58 | 19.50% | 8.20% | 11.27% |
| BCRX | BIOCRYST PHARMACEUTICALS INC | A | B | $1.51B | N/A | -7.40% | 22.20% | 6.00% | -2.08 | 2.25 | 97.00% | -6.40% | 11.15% |
| DCO | DUCOMMUN INC | A | B | $1.37B | 5.20% | 3.10% | 5.88% | 7.00% | 0.63 | 3.34 | 25.60% | 4.50% | 7.11% |
| CRTO | CRITEO SA | A | B | $1.17B | 15.50% | 7.80% | 16.77% | 50.50% | 0.79 | 1.33 | 53.80% | 8.60% | 11.21% |
| ANAB | ANAPTYSBIO INC | A | B | $996.78M | -1,101.20% | -21.20% | -26.84% | -13.70% | -13.00 | 8.68 | 100.00% | -49.90% | -49.89% |
| EVER | EVERQUOTE INC | A | A | $898.54M | 34.20% | 22.90% | 31.15% | 575.90% | 0.46 | 2.82 | 96.80% | 8.40% | 8.53% |
| NRDS | NERDWALLET INC | A | B | $897.13M | 8.20% | 6.70% | 0.55% | 1.50% | 0.28 | 2.68 | 90.80% | 4.00% | 0.29% |
| UDMY | UDEMY INC | A | B | $778.72M | -1.70% | -0.60% | 0.04% | -0.40% | 1.79 | 1.35 | 65.00% | -0.50% | 0.01% |
| TBPH | THERAVANCE BIOPHARMA INC | A | A | $752.90M | 6.90% | 3.50% | 11.49% | 15.90% | 0.90 | 6.71 | 100.00% | 16.90% | 55.25% |
| AKBA | AKEBIA THERAPEUTICS INC | A | C | $556.79M | N/A | -18.90% | -9.98% | -30.20% | 11.62 | 2.23 | 68.00% | -24.50% | -11.82% |
| EGHT | 8X8 INC | A | C | $300.01M | -18.00% | -3.00% | 1.06% | 1.10% | 4.34 | 1.18 | 67.50% | -3.00% | 0.75% |
| NATR | NATURES SUNSHINE PRODUCTS INC | A | B | $249.19M | 8.60% | 5.70% | 13.40% | 21.70% | 0.56 | 2.27 | 71.80% | 3.10% | 5.20% |
| ELMD | ELECTROMED INC | A | A | $210.90M | 17.50% | 14.50% | 23.73% | 37.60% | 0.25 | 4.31 | 78.10% | 11.80% | 16.07% |
| INFU | INFUSYSTEM HOLDINGS INC | A | A | $203.36M | 9.90% | 5.40% | 13.46% | 10.50% | 0.78 | 1.90 | 55.40% | 3.90% | 7.65% |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.